# Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve

> **NCT02268032** · PHASE1 · COMPLETED · sponsor: **Laboratorios Andromaco S.A.** · enrollment: 94 (actual)

## Conditions studied

- Healthy Women
- Infertility, Female

## Interventions

- **DRUG:** DHEA
- **DRUG:** Another Androgenic Agent (VRaA)
- **DRUG:** Fixed combination of 2 androgenic agents (VR2A)

## Key facts

- **NCT ID:** NCT02268032
- **Lead sponsor:** Laboratorios Andromaco S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-15
- **Primary completion:** 2016-08-31
- **Final completion:** 2016-08-31
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2019-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02268032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02268032, "Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02268032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*